Friday 20 September 2019

Microelectronic Medical Implants Market Worth $57.12 Billion By 2025

The global Microelectronic Medical Implants Market size is anticipated to reach USD 57.12 billion by 2025, according to a new report by Grand View Research, Inc., registering a 9.8% CAGR during the forecast period. Increasing prevalence of cardiac disorders, epilepsy, and Parkinson’s disease, growing regulatory approvals for new devices and equipment, rising geriatric population, and introduction of new products are key factors driving market growth. 
Regulatory authorities such as U.S. FDA have approved several new products and devices to be used by end users, most of which are equipped with new and innovative technologies that cater to varied consumer demands. These technologies also increase the ease of use of these products. For instance, in July 2017, Cochlear Ltd. introduced to the market a cochlear implant sound processor for iPhone. The U.S. FDA approved this innovation in June 2017.
Increasing prevalence of diseases such as epilepsy, cardiac disorders, and Parkinson’s disease have upped the sales of microelectronic electronic implants such as defibrillators, pacemakers, and neurostimulators. As per WHO, approximately 50 million people have epilepsy, globally, making it one of the most common neurological disorders. The condition can be treated using neurostimulators that prevent seizures.

U.S. microelectronic medical implants market
Further key findings from the study suggest:
  • By product, the pacemakers and defibrillators segment accounted for the largest share in 2016 owing to increasing prevalence of cardiovascular diseases and rising geriatric population
  • RF technology accounted for the largest share in 2016 as it is employed in wireless implants and helps researchers and clinicians monitor patient health, capture physiological data, and study normal and abnormal functioning of the body
  • North America commanded the largest share in the microelectronic medical implants market in 2016 and is expected to maintain its position over the forecast period. This is owing to favorable government policies, increasing FDA approvals for various medical devices in U.S., and high incidence of cardiac diseases
  • Key market players include Zimmer Biomet Holdings, Inc.; Cochlear Ltd.; Medtronic plc; Abbott Laboratories; Zoll Medical; Boston Scientific Corporation; LivaNova PLC; Biotronik; Schiller; and Koninklijke Philips N.V.
 About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James

Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email:
sales@grandviewresearch.com
For More Information:
https://www.grandviewresearch.com
Blog:  https://healthcareforecastreport.blogspot.com/


No comments:

Post a Comment

Insulin Delivery Devices Market To Reach $28.06 Billion By 2030

  The global  Insulin Delivery Devices Market  size was estimated at USD 28.06 billion in 2030 and is expected to grow at a CAGR of 7.89% fr...